Distinguished in Obesity

Patrick Schrauwen

Leiden, ZH, NL 
Distinguished in Obesity
Leiden, ZH, NL 
OverviewLocationsClinical Research

Overview

Patrick Schrauwen practices in Leiden, Netherlands. Mr. Schrauwen is rated as a Distinguished expert by MediFind in the treatment of Obesity. His top areas of expertise are Type 2 Diabetes (T2D), Obesity, Non-Alcoholic Fatty Liver Disease, and Cerebral Hypoxia.

His clinical research consists of co-authoring 214 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 48 articles in the study of Obesity.

Gender
Male

Locations

Leiden, ZH, Netherlands
Other Locations
Maastricht, LI, Netherlands
Wageningen, GE 6700AN, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

To Examine the Effect of Dietary Supplementation With Fish Oils With Dairy or Plant Based Lipids on Mitochondrial, Physical, and Cognitive Function, in Elderly Humans
To Examine the Effect of Dietary Supplementation With Fish Oils With Dairy or Plant Based Lipids on Mitochondrial, Physical, and Cognitive Function, in Elderly Humans
Enrollment Status: Terminated
Publish Date: November 13, 2020
Intervention Type: Dietary supplement
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Cross-over Phase II Study to Evaluate the Effect of a 6-week Elafibranor (120mg) Treatment Administered Once Daily on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
A Double-Blind, Placebo-Controlled, Cross-over Phase II Study to Evaluate the Effect of a 6-week Elafibranor (120mg) Treatment Administered Once Daily on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
Enrollment Status: Terminated
Publish Date: August 31, 2020
Intervention Type: Drug
Study Phase: Phase 2
Effects of Resveratrol on Insulin Sensitivity, Brown Adipose Tissue and Metabolic Profile in First-degree Relatives of Type 2 Diabetic Patients
Effects of Resveratrol on Insulin Sensitivity, Brown Adipose Tissue and Metabolic Profile in First-degree Relatives of Type 2 Diabetic Patients
Enrollment Status: Completed
Publish Date: August 08, 2017
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 2 Less Clinical Trials

214 Total Publications

Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals.
Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals.
Journal: Metabolism: clinical and experimental
Published: May 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schrauwen's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile